BCAL Diagnostics Limited (ASX:BDX)
Australia · Delayed Price · Currency is AUD 0.0860
+0.0160 (22.86%)
Sep 17, 2026, 3:34 PM AEST
BCAL Diagnostics Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 1.59 | 4.52 | 6.47 | 3.17 | 5.57 |
Short-Term Investments | - | - | - | - | 4 |
Cash & Short-Term Investments | 1.59 | 4.52 | 6.47 | 3.17 | 9.57 |
Cash Growth | -64.92% | -30.13% | 103.93% | -66.84% | 180.88% |
Accounts Receivable | 0.06 | - | - | - | - |
Other Receivables | 2.32 | 2.59 | 2.78 | 2.69 | 0.79 |
Receivables | 2.38 | 2.59 | 2.78 | 2.69 | 0.79 |
Prepaid Expenses | 0.11 | 0.08 | 0.08 | 0.34 | 0.09 |
Total Current Assets | 4.07 | 7.2 | 9.34 | 6.2 | 10.46 |
Property, Plant & Equipment | 2.03 | 2.7 | 2.89 | 2.17 | 0.14 |
Long-Term Investments | 1.55 | - | - | - | - |
Other Intangible Assets | - | 0.02 | 0.04 | - | - |
Total Assets | 7.66 | 9.91 | 12.27 | 8.37 | 10.59 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 0.74 | 0.55 | 0.74 | 1.58 | 0.28 |
Accrued Expenses | 0.28 | 0.59 | 0.95 | 0.48 | 0.63 |
Short-Term Debt | 1.4 | 1.3 | - | - | - |
Current Portion of Long-Term Debt | 0.12 | 0.27 | 0.24 | - | - |
Current Portion of Leases | 0.27 | 0.22 | 0.2 | 0.16 | - |
Other Current Liabilities | 0.19 | 0.17 | 0.46 | 0.04 | 0.05 |
Total Current Liabilities | 3 | 3.11 | 2.6 | 2.26 | 0.95 |
Long-Term Debt | 4.94 | 0.12 | 0.4 | - | - |
Long-Term Leases | 0.19 | 0.46 | 0.68 | 0.9 | - |
Other Long-Term Liabilities | 0.36 | - | - | 0 | - |
Total Liabilities | 8.49 | 3.69 | 3.68 | 3.16 | 0.95 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 34.01 | 33.83 | 28.9 | 19.28 | 18.87 |
Retained Earnings | -35.42 | -28.08 | -20.98 | -14.61 | -9.55 |
Comprehensive Income & Other | 0.59 | 0.47 | 0.67 | 0.55 | 0.32 |
Shareholders' Equity | -0.83 | 6.22 | 8.59 | 5.21 | 9.64 |
Total Liabilities & Equity | 7.66 | 9.91 | 12.27 | 8.37 | 10.59 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 6.92 | 2.38 | 1.52 | 1.06 | - |
Net Cash (Debt) | -5.33 | 2.14 | 4.95 | 2.11 | 9.57 |
Net Cash Growth | - | -56.68% | 134.25% | -77.93% | 180.88% |
Net Cash Per Share | -0.01 | 0.01 | 0.02 | 0.01 | 0.05 |
Filing Date Shares Outstanding | 368.68 | 365.97 | 357.79 | 243.09 | 211.44 |
Total Common Shares Outstanding | 368.68 | 365.97 | 314.29 | 212.31 | 207.44 |
Working Capital | 1.07 | 4.09 | 6.74 | 3.94 | 9.5 |
Book Value Per Share | -0.00 | 0.02 | 0.03 | 0.02 | 0.05 |
Tangible Book Value | -0.83 | 6.2 | 8.55 | 5.21 | 9.64 |
Tangible Book Value Per Share | -0.00 | 0.02 | 0.03 | 0.02 | 0.05 |
Machinery | 3.14 | 3.24 | 2.48 | 1.2 | 0.21 |